期刊论文详细信息
Journal of Nanobiotechnology
Antimicrobial effectiveness of silver nanoparticles co-stabilized by the bioactive copolymer pluronic F68
Marcelo Martins Seckler1  Adalberto Pessoa Jr2  Angela Faustino Jozala2  Carolina Alves dos Santos1 
[1] Department of Chemical Engineering of the Polytechnic School, University of São Paulo (USP), São Paulo, Brazil;Department of Biochemical and Pharmaceutical Technology, University of São Paulo (USP), São Paulo, Brazil
关键词: Gram-negative;    Gram-positive;    Minimal inhibitory concentration;    Pluronic™;    Polymers;    Silver nanoparticles;   
Others  :  821181
DOI  :  10.1186/1477-3155-10-43
 received in 2012-09-19, accepted in 2012-11-18,  发布年份 2012
PDF
【 摘 要 】

Background

Silver nanoparticles (AgNps) have attracted much interest in biomedical engineering, since they have excellent antimicrobial properties. Therefore, AgNps have often been considered for incorporation into medical products for skin pathologies to reduce the risk of contamination. This study aims at evaluating the antimicrobial effectiveness of AgNps stabilized by pluronic™ F68 associated with other polymers such as polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP).

Methods

AgNps antimicrobial activity was evaluated using the minimum inhibitory concentration (MIC) method. The action spectrum was evaluated for different polymers associated with pluronic™ F68 against the gram negative bacteria P. aeuroginosa and E. coli and the gram positive bacteria S. Aureus.

Results

AgNps stabilized with PVP or PVA and co-stabilized with pluronic™ F68 are effective against E. coli and P. aeruginosa microorganisms, with MIC values as low as 0.78% of the concentration of the original AgNps dispersion. The antimicrobial action against S. aureus is poor, with MIC values not lower than 25%.

Conclusions

AgNps stabilized by different polymeric systems have shown improved antimicrobial activity against gram-negative microorganisms in comparison to unstabilized AgNps. Co-stabilization with the bioactive copolymer pluronic™ F68 has further enhanced the antimicrobial effectiveness against both microorganisms. A poor effectiveness has been found against the gram-positive S. aureus microorganism. Future assays are being delineated targeting possible therapeutic applications.

【 授权许可】

   
2012 dos Santos et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140712070248769.pdf 315KB PDF download
Figure 1. 87KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Ragaseema VM, Unnikrishnan S, Kalliyana Krishnan V, Krishnan Lissy K: The antithrombotic and antimicrobial properties of PEG-protected silver nanoparticle coated surfaces. Biomaterials 2012, 33:3083-3092.
  • [2]Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ: Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 2004, 54:1019-1024.
  • [3]Irwin P, Martin J, Nguyen LH, He Y, Gehring A, Chen CY: Antimicrobial activity of spherical silver nanoparticles prepared using a biocompatible macromolecular capping agent: evidence for induction of a greatly prolonged bacterial lag phase. J Nanobiotechnology 2010, 8:34. BioMed Central Full Text
  • [4]Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM: Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007, 12:527-534.
  • [5]Pal S, Tak YK, Song JM: Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 2007, 73:1712-1720.
  • [6]Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI: Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 2005, 5:244-249.
  • [7]Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, Yacaman MJ: The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
  • [8]Sondi I, Salopek-Sondi B: Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 2004, 275:177-182.
  • [9]Panacek A, Kvitek L, Prucek R, Kolar M, Vecerova R, Pizurova N, Sharma VK, Nevecna T, Zboril R: Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006, 110:16248-16253.
  • [10]Cho KH, Park JE, Osaka T, Park SG: The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim Acta 2005, 51:956-960.
  • [11]Kora AJ, Arunachalam J: Assessment of antibacterial activity of silver nanoparticles on Pseudomonas aeruginosa and its mechanism of action. World J Microbiol Biotechnol 2011, 27:1209-1216.
  • [12]Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ: Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology 2005, 3:6-16. BioMed Central Full Text
  • [13]Batrakova EV, Kabanov AV: Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release 2008, 130(2):98-106.
  • [14]Croy SR, Kwon GS: The effects of pluronic block copolymers on the aggregation state of nystatin. J Control Release 2004, 95:161-171.
  • [15]Ma W-D, Hui X, Wang C, Nie S-F, Pan W-S: Pluronic F127-g-poly (acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. Int J Pharm 2008, 350:247-256.
  • [16]Briones E, Colino CI, Lanao JM: Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release 2008, 125:210-227.
  • [17]Santos CA, Ribeiro GB, Knirsch MC, Pessoa-Jr A, Penna TCV: Influence of pluronic F68 on Ceftazidime Biological Activity in Parenteral Solutions. J Pharm Sci 2010, 1:1-6.
  • [18]Chopra I: The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J Antimicrob Chemother 2007, 59:587-590.
  • [19]Martinez-Abad A, Lagaron JM, Ocio MJ: Development and characterization of silver-based antimicrobial ethylene−vinyl alcohol copolymer (EVOH) films for food-packaging applications. J Agric Food Chem 2012, 60(21):5350-5359.
  • [20]Bouwmeester H, Dekkers S, Noordam MY, Hagens WI, Bulder AS, de Heer C, ten Voorde SECG, Wijnhoven SWP, Marvin HPJ, Sips AJAM: Review of health safety aspects of nanotechnologies in food production. Regul Toxicol Pharmacol 2009, 53:52-62.
  • [21]Beiersdorf B: Nivea spray silver protect. www.nivea.com/products/show/25795
  • [22]Silver Care Plus self sanitizing toothbrush. www.dentist.net/silver-care-plus.asp
  • [23]He L, Gao S-y, Wu H, Liao X-p, He Q, Shi B: Antibacterial activity of silver nanoparticles stabilized on tannin-grafted collagen fiber. Mater Sci Eng C 2012, 32:1050-1056.
  • [24]Abdullin TI, Bondar OV, Shtyrlin YG, Kahraman M, Culha M: Pluronic block copolymer-mediated interactions of organic compounds with noble metal nanoparticles for SERS analysis. Langmuir 2010, 26:5153-5159.
  • [25]Santos CA, Oliveira RA, Seckler MM: Optimization of green synthesis method for silver nanoparticles. ISIC (18th International Symposium on Industrial crystallization; 2011.
  • [26]Mazzola PG, Jozala AF, Novaes LCL, Moriel P, Vessoni Penna TC: Minimal inhibitory concentration (MIC) determination of disinfectant and/or sterilizing agents. Braz J Pharm Sci 2009, 45:2.
  文献评价指标  
  下载次数:14次 浏览次数:22次